Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that its wholly-owned foreign enterprise, CBD Biotechnology Co. Ltd., has officially filed a record of its first line of non-industrial hemp-infused skin care products with the China Food and Drug Administration (CFDA). These products, which comprise the new ‘CBD Magic Hemp Series’ skin care line, are expected to launch in late August and early September of this year, positioning CBD Biotechnology as a first-mover in an untapped segment of China’s skin care industry. “As one of the first skin care products containing CBD extract marketed in China, CBD Magic Hemp Series expects to capture 100% of China’s market share in this novel skin care products category,” Summer Yun, CEO of CBD Biotechnology, stated in the news release. “Although a catalogue published by the CFDA, indicates that cannabis sativa leaf extract can legally be added to skin care products, it appears that Chinese skin care manufacturers have not yet entered this market, enabling CBD Biotechnology’s skin care products to proudly take the lead with its innovative product line.” Per the update, China currently has the world’s second-largest consumer market for skin care products, with the current market size exceeding $44.4 billion.
Read the full article
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Read More